Evidence map›Paper›PMID 33393969›Full record

ArticleInvestigative ophthalmology & visual science2021

Temporal Relationship Between Visual Field, Retinal and Microvascular Pathology Following 125I-Plaque Brachytherapy for Uveal Melanoma.

Michelle R Tamplin, Wenxiang Deng, Mona K Garvin, Elaine M Binkley, Daniel E Hyer, John M Buatti, Johannes Ledolter, H Culver Boldt, Randy H Kardon, Isabella M Grumbach

Open access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Michelle R TamplinFree Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, United States.
Wenxiang DengIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States.
Mona K GarvinIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States.
Elaine M BinkleyDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, United States.
Daniel E HyerDepartment of Radiation Oncology, University of Iowa, Iowa City, Iowa, United States.
John M BuattiDepartment of Radiation Oncology, University of Iowa, Iowa City, Iowa, United States.
Johannes LedolterIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States.
H Culver BoldtDepartment of Ophthalmology and Visual Sciences, University of Iowa, Iowa City, Iowa, United States.
Randy H KardonIowa City VA Center for the Prevention and Treatment of Visual Loss, Iowa City, Iowa, United States.
Isabella M GrumbachFree Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, Iowa, United States.
University of Iowa · USIowa City VA Health Care System · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
TRAINING PROGRAM IN FREE RADICAL AND RADIATION BIOLOGYT32CA078586 · NCI · UNIVERSITY OF IOWA · PI SPITZ, DOUGLAS ROBERT · 1999 to 2024
$5.7M
Laser speckle flowgraphy as early indicator of microvasculopathy in radiation-induced vision lossR01EY031544 · NEI · UNIVERSITY OF IOWA · PI GRUMBACH, ISABELLA MARIA, KARDON, RANDY H. · 2020 to 2024
$2.8M
Center for the Prevention and Treatment of Visual LossI50RX003002 · VA · IOWA CITY VA MEDICAL CENTER · PI RANDY H. KARDON, MARKUS H. KUEHN · 2019 to 2026
–
NCI NIH HHS T32 CA078586NEI NIH HHS R01 EY031544RRD VA I50 RX003002
6 · The paper itself

Abstract

Purpose: To define the temporal relationship of vascular versus neuronal abnormalities in radiation retinopathy. Methods: Twenty-five patients with uveal melanoma treated with brachytherapy and sixteen controls were tested. Functional outcome measures included visual acuity and threshold perimetry (HVF 10-2), while structural outcomes included retinal thickness by OCT and vascular measures by OCT angiography and digital fundus photography. The degree of structural abnormality was determined by intereye asymmetry compared with normal subject asymmetry. Diagnostic sensitivity and specificity of each measure were determined using receiver operating characteristic curves. The relationships between the outcome measures were quantified by Spearman correlation. The effect of time from brachytherapy on visual function, retinal layer thickness, and capillary density was also determined. Results: Within the first 2 years of brachytherapy, outcome measures revealed visual field loss and microvascular abnormalities in 38% and 31% of subjects, respectively. After 2 years, they became more prevalent, increasing to 67% and 67%, respectively, as did retinal thinning (50%). Visual field loss, loss of capillary density, and inner retinal thickness were highly correlated with one another. Diagnostic sensitivity and specificity were highest for abnormalities in digital fundus photography, visual field loss within the central 10°, and decrease in vessel density. Conclusions: Using quantitative approaches, radiation microvasculopathy and visual field defects were detected earlier than loss of inner retinal structure after brachytherapy. Strong correlations eventually developed between vascular pathology, change in retinal thickness, neuronal dysfunction, and radiation dose. Radiation-induced ischemia seems to be a primary early manifestation of radiation retinopathy preceding visual loss.

Indexed as

AdultAgedAged, 80 and overBrachytherapyFemaleFluorescein AngiographyHumansIodine RadioisotopesMaleMelanomaMiddle AgedRadiation InjuriesRetinal DiseasesRetinal VesselsROC CurveTomography, Optical CoherenceIodine-125Iodine Radioisotopes

Identifiers

PMID33393969
PMCPMC7794259
OpenAlexW3118798044

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.